These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 34593004)

  • 1. Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections.
    Farinholt T; Doddapaneni H; Qin X; Menon V; Meng Q; Metcalf G; Chao H; Gingras MC; Avadhanula V; Farinholt P; Agrawal C; Muzny DM; Piedra PA; Gibbs RA; Petrosino J
    BMC Med; 2021 Oct; 19(1):255. PubMed ID: 34593004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission event of SARS-CoV-2 Delta variant reveals multiple vaccine breakthrough infections.
    Farinholt T; Doddapaneni H; Qin X; Menon V; Meng Q; Metcalf G; Chao H; Gingras MC; Farinholt P; Agrawal C; Muzny DM; Piedra PA; Gibbs RA; Petrosino J
    medRxiv; 2021 Jul; ():. PubMed ID: 34268529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021.
    Marques AD; Sherrill-Mix S; Everett JK; Reddy S; Hokama P; Roche AM; Hwang Y; Glascock A; Whiteside SA; Graham-Wooten J; Khatib LA; Fitzgerald AS; Moustafa AM; Bianco C; Rajagopal S; Helton J; Deming R; Denu L; Ahmed A; Kitt E; Coffin SE; Newbern C; Mell JC; Planet PJ; Badjatia N; Richards B; Wang ZX; Cannuscio CC; Strelau KM; Jaskowiak-Barr A; Cressman L; Loughrey S; Ganguly A; Feldman MD; Collman RG; Rodino KG; Kelly BJ; Bushman FD
    mBio; 2021 Feb; 13(1):e0378821. PubMed ID: 35130727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant.
    Zhang M; Liang Y; Yu D; Du B; Cheng W; Li L; Yu Z; Luo S; Zhang Y; Wang H; Zhang X; Zhang W
    Int J Biol Sci; 2022; 18(2):889-900. PubMed ID: 35002532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City.
    Duerr R; Dimartino D; Marier C; Zappile P; Wang G; Lighter J; Elbel B; Troxel AB; Heguy A
    J Clin Invest; 2021 Sep; 131(18):. PubMed ID: 34375308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of mRNA BNT162b2 COVID-19 vaccine against SARS-CoV-2 Delta variant among elderly residents from a long-term care facility, South of France, May 2021.
    Sánchez Ruiz MA; Adonias G; Robaglia-Schlupp A; Rapilly F; Chabert M; Ramalli L; Reilhes O; Bruel C; Malfait P; Chaud P
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2586-2591. PubMed ID: 35442474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active viral shedding in a vaccinated hospitalized patient infected with the delta variant (B.1.617.2) of SARS-CoV-2 and challenges of de-isolation.
    Alshukairi AN; Al-Omari A; Al-Tawfiq JA; El-Kafrawy SA; El-Daly MM; Hassan AM; Faizo AA; Alandijany TA; Dada A; Saeedi MF; Alhamlan FS; Al Hroub MK; Qushmaq I; Azhar EI
    J Infect Public Health; 2022 Jun; 15(6):628-630. PubMed ID: 35576779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral response and breakthrough infections with SARS-CoV-2 B.1.617.2 variant in vaccinated maintenance hemodialysis patients.
    Wand O; Nacasch N; Fadeela A; Shashar M; Grupper A; Benchetrit S; Erez D; Shitrit P; Cohen-Hagai K
    J Nephrol; 2022 Jun; 35(5):1479-1487. PubMed ID: 35175577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines.
    Brunner-Ziegler S; Spath T; Kornek G; König F; Parschalk B; Schnetzinger M; Straßl RP; Savic R; Foit A; Resch H; Thalhammer F
    Clin Microbiol Infect; 2022 Apr; 28(4):596-601. PubMed ID: 34915073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants.
    Eyre DW; Taylor D; Purver M; Chapman D; Fowler T; Pouwels KB; Walker AS; Peto TEA
    N Engl J Med; 2022 Feb; 386(8):744-756. PubMed ID: 34986294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study.
    Gazit S; Shlezinger R; Perez G; Lotan R; Peretz A; Ben-Tov A; Herzel E; Alapi H; Cohen D; Muhsen K; Chodick G; Patalon T
    Clin Infect Dis; 2022 Aug; 75(1):e545-e551. PubMed ID: 35380632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants.
    Miyamoto S; Arashiro T; Adachi Y; Moriyama S; Kinoshita H; Kanno T; Saito S; Katano H; Iida S; Ainai A; Kotaki R; Yamada S; Kuroda Y; Yamamoto T; Ishijima K; Park ES; Inoue Y; Kaku Y; Tobiume M; Iwata-Yoshikawa N; Shiwa-Sudo N; Tokunaga K; Ozono S; Hemmi T; Ueno A; Kishida N; Watanabe S; Nojima K; Seki Y; Mizukami T; Hasegawa H; Ebihara H; Maeda K; Fukushi S; Takahashi Y; Suzuki T
    Med; 2022 Apr; 3(4):249-261.e4. PubMed ID: 35261995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BNT162b2 vaccine protection against omicron and effect of previous infection variant and vaccination sequence among children and adolescents in Singapore: a population-based cohort study.
    Yung CF; Pang D; Kam KQ; Lye DC; Ong B; Chong CY; Tan KB
    Lancet Child Adolesc Health; 2023 Jul; 7(7):463-470. PubMed ID: 37201540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of SARS-CoV-2 variant breakthrough infection in fully immunized solid organ transplant recipients.
    Almaghrabi RS; Alhamlan FS; Dada A; Al-Tawfiq JA; Al Hroub MK; Saeedi MF; Alamri M; Alhothaly B; Alqasabi A; Al-Qahtani AA; Al-Omari A; Alshukairi AN
    J Infect Public Health; 2022 Jan; 15(1):51-55. PubMed ID: 34906898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January-March 2021.
    Sadigh KS; Kugeler KJ; Bressler S; Massay SC; Schmoll E; Milroy L; Cavanaugh AM; Sierocki A; ; Fischer M; Nolen LD
    BMC Infect Dis; 2022 Sep; 22(1):718. PubMed ID: 36050630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.
    Tartof SY; Slezak JM; Fischer H; Hong V; Ackerson BK; Ranasinghe ON; Frankland TB; Ogun OA; Zamparo JM; Gray S; Valluri SR; Pan K; Angulo FJ; Jodar L; McLaughlin JM
    Lancet; 2021 Oct; 398(10309):1407-1416. PubMed ID: 34619098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant Is Associated With Higher Recovery of Infectious Virus Compared to the Alpha Variant in Both Unvaccinated and Vaccinated Individuals.
    Huai Luo C; Paul Morris C; Sachithanandham J; Amadi A; Gaston DC; Li M; Swanson NJ; Schwartz M; Klein EY; Pekosz A; Mostafa HH
    Clin Infect Dis; 2022 Aug; 75(1):e715-e725. PubMed ID: 34922338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
    Hacisuleyman E; Hale C; Saito Y; Blachere NE; Bergh M; Conlon EG; Schaefer-Babajew DJ; DaSilva J; Muecksch F; Gaebler C; Lifton R; Nussenzweig MC; Hatziioannou T; Bieniasz PD; Darnell RB
    N Engl J Med; 2021 Jun; 384(23):2212-2218. PubMed ID: 33882219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID-19 vaccination.
    Torres I; Bellido-Blasco JB; Gimeno C; Burgos JS; Albert E; Moya-Malo R; Gascó-Laborda JC; Tornero A; Soriano J; Meseguer-Ferrer N; Martínez-Serrano M; Ortíz-Rambla J; Buj H; Hernández N; Peiró S; Salas D; Limón R; Vanaclocha H; Sánchez-Payá J; Díez-Domingo J; Comas I; González-Candelas F; Navarro D;
    J Med Virol; 2022 Aug; 94(8):3776-3782. PubMed ID: 35445415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.